1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Elevated expression of complement factor I in lung cancer cells associates with shorter survival–Potentially via non-canonical mechanism
- Contribution to journal › Article
- 2019
-
Mark
‘Stealth’ corporate innovation : an emerging threat for therapeutic drug development
Mastellos, Dimitrios C. ; Blom, Anna M. LU
; Connolly, E. Sander
; Daha, Mohamed R.
; Geisbrecht, Brian V.
; Ghebrehiwet, Berhane
; Gros, Piet
; Hajishengallis, George
; Holers, V. Michael
and Huber-Lang, Markus
, et al.
(2019)
In Nature Immunology
20(11).
p.1409-1413
- Contribution to journal › Debate/Note/Editorial
- 2018
-
Mark
Complement C4d-specific antibodies for the diagnosis of lung cancer
- Contribution to journal › Article
- 2017
-
Mark
Strategies to design clinical studies to identify predictive biomarkers in cancer research
- Contribution to journal › Scientific review
- 2009
-
Mark
Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack.
Okroj, Marcin LU ; Corrales, Leticia ; Stokowska, Anna ; Pio, Ruben and Blom, Anna LU
(2009)
In Cancer immunology, immunotherapy
58.
p.1773-1782
- Contribution to journal › Article
- 2008
-
Mark
Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors
Okroj, Marcin LU ; Hsu, Yi-Fan ; Ajona, Daniel ; Pio, Ruben and Blom, Anna LU
(2008)
In Molecular Immunology
45(1).
p.169-179
- Contribution to journal › Article